Predicted Trait | |
Reported Trait | Estrogen receptor positive breast cancer |
Mapped Trait(s) | estrogen-receptor positive breast cancer (EFO_1000649) |
Score Construction | |
PGS Name | ERpos.prs |
Development Method | |
Name | Thresholding Stepwise Forward Logistic Regression |
Parameters | LD r2 < 0.9, p value <0.05 |
Variants | |
Original Genome Build | hg19 |
Number of Variants | 29,309 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000621 |
Citation (link to publication) | Gao G et al. Hum Mol Genet (2022) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 92.1% African: 7.9% 172,246 individuals (100%) |
PGS Evaluation | African: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
Europe PMC: 30554720 |
[
|
European | BCAC |
— | [
|
African American or Afro-Caribbean (African American, African, and African Barbadian) |
AABC, AMBER, BCAC, GBHS, ROOT |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM021274 | PSS011673| African Ancestry| 5,821 individuals |
PGP000621 | Gao G et al. Hum Mol Genet (2022) |
Reported Trait: Estrogen receptor positive breast cancer | OR: 1.49 [1.39, 1.6] | AUROC: 0.608 [0.588, 0.627] | — | age, consortium/study, and top 10 principal components | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011673 | — | — | [
|
Mean = 52.7 years Sd = 12.7 years |
African American or Afro-Caribbean (African American, African, and African Barbadian) |
— | AABC, AMBER, BCAC, GBHS, ROOT | — |